Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
AvenCell Therapeutics, Inc.
City of Hope Medical Center
Allogene Therapeutics
Ossium Health, Inc.
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Celgene
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Therapeutic Advances in Childhood Leukemia Consortium
Beijing Immunochina Medical Science & Technology Co., Ltd.
Columbia University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sanofi
M.D. Anderson Cancer Center
University of Kentucky
Columbia University
M.D. Anderson Cancer Center
Northwestern University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center